Norwegian Block Exchange AS (NBX) was established in 2018 and is working with distributed ledger technologies. NBX’s offices are located at Fornebu in Bærum, Norway. NBX is building the next-generation cryptocurrency exchange to set a new standard for security, transparency, and reliability within cryptocurrency trading. We start from scratch and only use the best-in-class solutions and technology. The company will also work on the adaption of DLT to find better and smarter ways for businesses across industries to operate. NBX has global ambitions and to reach the goals we build the company by working with the best people and partners.

Material Mapper’s vision is to create a market of scale for secondary building materials by mapping them in Europe and leading the transition towards a closed-loop circular construction and demolition industry. The European construction industry is urgently lacking clear, centralized access to information about secondary building materials available in their area, due to the fragmentation and inconsistency with which these public data are captured and stored. This makes building planning with quality secondary building materials time and cost-intensive for stakeholders, in turn making it difficult to comply with the EU’s Waste Directive of 70% recycled/re-used building materials. Our young, multi-award-winning company is planning to launch a project over 24 months to build a breakthrough innovation for the whole of Europe using artificial intelligence and machine learning that will extract, read, evaluate, and forecast quantities of secondary building materials for the user, making future planning for property developers seamless through our platform. We are confident that our product is unique and that we have no direct competition. By combining our deep technology, partnership development, and B2B sales expertise, we are already working closely with major industry actors to harness insights and their existing networks for our customer base.

At Navidium sustainability is our Number 1 Value. The maritime industry needs to change to be feasible in the future as a global transport mechanism. We believe at Navidium we're building part of the puzzle to solve this problem by using exciting data-driven products that open up a world of interoperable possibilities and we're excited to be driving this change forward with our customers and partners. If you're excited by any of the following then make sure you get in touch- Blue Economy- Software Development (Kafka, k8s, .net, timeserie, MQTT, microservices)- Front End Development (Mainly React)- Maritime Industry- Data Science (Physics and ML based hybrid modeling)- Data Engineering- Voyage Optimisation- Performance Monitoring- Environmental Reporting

We believe that live esports should be available to everyone, in a way that makes it easy to follow and easy to understand. Our goal is to make it available anytime, anywhere, and to unify it all in one place. That’s why we’re building a platform that will revolutionize the way you consume live esports.

Med-Storm's Skin Conductance Algesimeter (SCA) uses the principle of skin conductance to measure pain, allowing us to titrate the right amount of pain medication for each, individual patient. This award-winning technology is not affected by changes in blood circulation, heart rate, hypotensia, environmental temperatures, and hypoxia, and shows low variation between individuals at the same level of pain. The pain monitor can be used on patients as young as 23 weeks of gestational age, as well as geriatric patients. MS is currently working on a miniaturized and wireless version of the SCA.

We are simplifying personal health control, by making clinically proven testing readily available to the public. Tigeni is a healthcare and technology company that makes blood screening convenient, safe and monitorable in a simple, personal and secure health dashboard. Tigeni offers at-home-finger-prick-test, monitoring and test results with professional lifestyle guidance, accessible on PC and mobile. Through innovation, information and motivation, we are empowering our customers to take control of their health and live better lives.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Nordic Unmanned is one of the world’s leading suppliers of drones and data capture solutions. With our wide customer base and extensive experience, we’re able to provide our clients with high-end products and services that meet their specific needs. Our goal is to help our clients achieve their desired outcomes through the use of unmanned systems and services, making them more efficient, effective, and profitable. We are continuously looking for talent, and we recommend any individual that might be interested in working at Nordic Unmanned, to either apply for one of our vacant positions or create a profile at https://jobs.nordicunmanned.com/

Bookd AS ble etablert i 2021 og jobber med å forenkle bookingprosesser i underholdningsbransjen. Vårt fokus er å tilby underholdning på en enkel og intuitiv måte til bedrifts- og privatarrangementer. Vi har utviklet en app (iOS) hvor man kan finne og booke underholdning på en enkel måte. Vi tilbyr artister, DJs, komikere, foredragsholdere, dansere, kokker og annen underholdning som passer til ulike typer arrangementer. I 2022 er målet å etablere seg i Norge før vi skal skalere videre til nye markeder.Vi har en stor profilbase, samt gode og etablerte partnerskap med flere av Norges største eventbyråer og bedrifter.

The Norwegian fashion brand BRGN was founded in 2015 by Ros-Mari Tobiassen Gaundal and Karine Trellevik Lunde. Their mission is to offer great alternatives to the traditional all-weather jacket, through high-quality garments and shoes that can be worn on any occasion and in any kind of weather. Their technical and waterproof products, designed for a functional and urban lifestyle, are now sold by over a hundred retailers in Norway, Germany, France, and the UK in addition to their two concept stores in Oslo and Bergen. BRGN set a new turnover record in 2021, at 25.8 MNOK. Up from 16. MNOK in 2020.

DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective. We use state-of-the-art methods to improve patients’ quality of life and help clinicians make more informed decisions. Our technology is based on pioneering research on utilizing artificial intelligence to increase the prognostic value from routine clinical pathology cancer tissue samples. The extensive research conducted at top universities (University in Oslo, Oxford University and University College of London) has been published in leading and high impact scientific journals such as The Lancet and Nature Reviews Cancer. These new methods have resulted in fully automated histotyping that provide objective and precise prognostic information that correlate and out-perform existing markers. This novel histotyping can guide selection of therapy to avoid over- and undertreatment. It can also make cancer drug development more effective by ensuring more precise diagnosis and prognosis, which is the fundament for precision medicine. Artificial intelligence is set for a breakthrough in medicine and several megatrends are pushing for new solutions in cancer diagnostics. Digital pathology and new AI algorithms will play a significant role in the future of medicine and hold multiple commercial opportunities. DoMore Diagnostics is at the forefront of the field and will bring these next generation products to the clinic.

SynPlan is an Artificial Intelligence/Machine Learning (AI/ML) solution to help healthcare organisations optimise workforce planning. SynPlan helps collect large amounts of data from a variety of sources, including internal (payroll, accounting,..) and external (weather,…) systems. Having this data presented on a dashboard allows healthcare leaders to get a holistic view of their organization in real-time, instead of waiting for their subordinates to collect data from multiple departments, which might take weeks to months. SynPlan uses advanced Artificial Intelligence technology to predict in advance the demand of healthcare as well as the absence of employees. The healthcare planners can adjust their plans, moving the right resources to where or when it needed the most. By using SynPlan, healthcare leaders can focus their time and energy on patient care rather than planning, improving both the well-being of patients and employees while keeping their SynPlan has a mission to ensure a better life for all healthcare workers and increase the quality of healthcare services. Our ambition is to go internationally to serve more than 20,000 hospitals and healthcare organisations worldwide.

Easee was created by three entrepreneurs in January 2018, with a vision of shaping the future of electricity. Easee develops and manufactures in Norway and we are passionate about developing products that our customers fall in love with. We have started by developing the world’s smartest charging robot for electric cars. A solution and an ecosystem that will give our customers a seamless experience. Shaping the power grid of the future is not something we can do alone, and collaboration is key. We therefore understand the importance of building relationships and establishing partners to join us on our journey.

Oceanness is a purpose-driven apparel brand, created to save the ocean. From eco-friendly apparel made from recycled plastic bottles, to removing plastic waste from the ocean and coastlines, everything we do is for the love of our ocean. Oceanness provide sustainable clothes made from recycled plastic bottles, and jewelry made from ocean plastic collected on the shores of Oslo and Grimstad. For every item sold, we collect 2 kg plastic waste, equivalent to 100 plastic bottles, from the ocean and coastlines in partnership with Plastic Bank. Our mission is simple - to save the ocean by having the world #DressWithPurpose In short, we want Oceanness to enable you to make the best sustainable choice you can without compromising on quality and style. Care to join the wave?

We are a startup passionate about facilitating great, beneficial relationships between companies and their leads. With support from notable investors and sizable clients, we aim at providing the foremost platform for attracting and engaging leads. We believe in authentic journeys - and inviting your customers to be a part of yours.